Ebola virus disease - World Health Organization (WHO)
2023年4月20日 · The symptoms of Ebola infection can be sudden and include fever, fatigue, muscle pain, headache and sore throat. These are followed by vomiting, diarrhoea, rash, and internal and external bleeding. The time from when someone gets infected to having symptoms is usually from 2 to 21 days.
Ebola virus disease - World Health Organization (WHO)
2022年12月9日 · The incubation period, that is, the time interval from infection with the virus to onset of symptoms, is from 2 to 21 days. A person infected with Ebola cannot spread the disease until they develop symptoms. Symptoms of EVD can be sudden and include: fever, fatigue, muscle, pain, headache, and sore throat.
Ebola viruses - World Health Organization (WHO)
The Ebola virus causes an acute, serious illness which is often fatal if untreated. Ebola virus disease (EVD) formerly known as Ebola haemorrhagic fever, is a severe, often fatal illness in humans. The virus causing the 2014–2016 West African outbreak belongs to the Zaire ebolavirus species. Ebola Vaccines
Ebola virus disease - World Health Organization (WHO)
Ebola virus disease (formerly known as Ebola haemorrhagic fever) is a rare but severe, often fatal , often fatal illness, with a death rate of up to 90% in humans caused by the Ebola virus, a member of the filovirus family. Death rates have varied from 25% to 90% in past outbreaks.
Lassa fever - World Health Organization (WHO)
2024年12月5日 · Lassa fever is known to be endemic in Benin, Ghana, Guinea, Liberia, Mali, Nigeria and Sierra Leone, but probably exists in other west African countries as well. The Lassa virus is primarily transmitted to humans via contact with food or household items contaminated with rodent urine or faeces.
Ebola virus disease: Vaccines - World Health Organization (WHO)
For individuals at imminent risk of exposure to Ebola (for example, health care professionals and those living in or visiting areas with an ongoing Ebola virus disease outbreak) who completed the Zabdeno and Mvabea 2-dose vaccination regimen, a Zabdeno booster vaccination should be considered if more than 4 months have passed since the second ...
Marburg virus disease - World Health Organization (WHO)
Marburg virus disease (MVD), formerly known as Marburg haemorrhagic fever, is a severe, often fatal illness in humans. The average MVD case fatality rate is around 50%. Case fatality rates have varied from 24% to 88% in past outbreaks.
Ebola virus disease - European Centre for Disease Prevention and …
Ebola also causes haemorrhagic symptoms including bloody diarrhoea, nosebleeds, vomiting blood, internal bleeding and bruises. Risk for people The risk of becoming infected is considered to be very low if infection prevention and control measures are followed, although the mortality rate is approximately 65% of diagnosed cases.
Ebola Virus Disease - PAHO/WHO | Pan American Health …
2019年7月17日 · Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a rare but severe, often fatal illness in humans. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. The average EVD case fatality rate is around 50%.
Surveillance and updates for Ebola and Marburg fevers
Risk of Ebola virus transmission through donated blood and other substances of human origin; Surveillance and updates. Ebola virus disease outbreak in Uganda; Ebola virus disease outbreak in Guinea; Ebola outbreaks in the Democratic Republic of the Congo; Ebola outbreak in West Africa 2013-2016. Ebola virus disease case definition for reporting ...